The Juxtopia Group Inc. is a 501c(3) not-for-profit organization established in 2000 and founded by Jayfus Tucker Doswell. Juxtopia®’s core business is developing human performance products, with a focus on augmented reality headsets and software services where speech is the primary human computer interface.

FiberCell Systems offers hollow fiber bioreactor systems to academic and biotechnology markets. The company’s bioreactors utilize new, state-of-the-art filtration rates that offer many advantages over conventional cell culture methods, and are used by NASA at the International Space Station and endorsed by the European Medicines Agency.

FiberCell developed and patented a novel method for generating gas delivery to hollow fiber cartridges. Instead of passively exchanging gas with a medium and flowing that medium through the cartridge, it delivers alternating amounts of medium and gas directly to the interior of the reactor. Rather than using pumps, gravity feed is utilized to circulate the medium in both directions. A device using these technologies would be an entirely new concept in bioreactor operating principles. This was the subject of the company’s MIPS project.

Manta Biofuel is a producer of renewable algal crude oil that is cost-competitive with traditional crude oil. The company employs technological advantages in a three-step process to produce crude oil from algae. The first is growing algae. Manta can convert algae from any source, leaving options open from farming to collecting natural blooms. For the second step, harvesting the algae, Manta uses a proprietary magnetic harvester that efficiently collects and concentrates algae. The company then converts the algae to crude oil through hydrothermal liquefaction (HTL).

Vasoptic Medical Inc. is a medical device company developing and commercializing high-quality, cost-effective products for the non invasive, dynamic assessment of retinal blood flow and vascular status. Vasoptic Medical has developed a low-cost, portable, noninvasive retinal imaging instrument (the XyCAM), which can complement fundus photographs with retinal blood flow information obtained at high spatio-temporal resolution without the introduction of any dyes. This handheld retinal imager has the potential to help detect a number of clinical conditions, including diabetic retinopathy (DR), glaucoma, and age-related macular degeneration. Early detection can often prevent vision loss. The XyCAM device is being designed to detect these conditions inn their earliest stages to help healthcare providers manage and prevent DR and glaucoma progression through a convenient, low-cost, minimally invasive procedure.

Airgility designs and manufactures unmanned aerial systems (UAS). The company’s mission is to develop and field the most versatile vertical takeoff and landing (VTOL) platforms.

Airgility’s flagship product, the HorseSHU, is a breakthrough VTOL aircraft leveraging a patent-pending lifting body with thrust vectoring propulsion. This ground-up design, while optimizing for conditions of vertical and forward flight regimes, offers the best combination of payload weight, payload volume, flight endurance, speed and mission flexibility.

BondTrue has developed a patented medical device that automates the process of surgical incisions and closures. The result is a fast, precise surgical wound that can be rapidly approximated and repaired. This significantly reduces surgical times and ensures excellent wound repair. Precise wound repair is associated with reduced scarring and decreased wound complications, including surgical wound infections.